In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Total Health

HIV & the Heart

Reviewed By:
David Slotnick, M.D.
Abdou Elhendy, MD, PhD, FACC, FAHA
Robert I. Hamby, M.D., FACC, FACP

Summary

Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) are names for different stages of the same viral infection that impairs a person’s immune system. It has long been understood that there is a link between HIV and the heart.

HIV-positive patients are at greater risk for a variety of heart-related conditions, including pericarditis (an inflammation of the pericardial sac around the heart), pleural effusions (fluid between the lungs and the chest wall), and coronary artery disease. HIV infection doubles the risk of a heart attack, according to recent research.

The reason for this link between HIV and heart-related conditions is unknown, but secondary infections that affect the heart muscle and pericardial sac have a greater chance of occurring in people The heart and lungs work together to pump oxygenated blood throughout the body (circulation).with compromised immune systems.

Additionally, some of the medications used to treat HIV patients have heart-related side effects. As drug therapy improves and prolongs the lives of HIV and AIDS patients, most researchers believe the number of HIV-positive cardiac cases will rise.

Most physicians rely on physical examinations presenting heart-related symptoms which would prompt a cardiac evaluation. Patients are urged to contact their physician immediately if they experience symptoms such as chest pain, shortness of breath or flu-like symptoms.

About HIV and the heart

Since acquired immune deficiency syndrome (AIDS) was first identified in the early 1980s, there has been clear evidence from autopsy reports that there is a link between human immunodeficiency virus (HIV, the virus that causes AIDS) and heart conditions. In fact, researchers with the American Heart Association (AHA) have identified HIV as a known risk factor for heart disease, along with diet, obesity, family history and other risk factors. In fact, people with HIV are almost twice as likely to have a heart attack than people without the virus.

HIV-related cardiac abnormalities affect both children and adults, and they are linked with shortened life expectancy. Heart conditions that have been associated with HIV include:

  • Pericarditis. This condition involves an inflammation of the pericardium – a thin sac surrounding the heart. It can cause severe chest pain (especially upon taking a deep breath), shortness of breath and heart failure, if left untreated. Physicians typically keep pericarditis patients in the hospital for several days to observe for any signs of an emergency condition called cardiac tamponade. If this emergency condition develops, the excess fluid in the pericardium will need to be drained through a needle, catheter or by surgery.

  • Pleural effusion. Fluid buildup in the space between the lungs and chest wall.

  • Pulmonary hypertension. High blood pressure in the blood vessels of the lungs. This can lead to right-sided heart failure (cor pulmonale).

  • Dilated cardiomyopathy. A type of heart disease in which the heart muscle is abnormally enlarged, thickened and/or stiffened. As a result, the heart muscle’s ability to pump blood is usually weakened. Some researchers have found a link between cardiomyopathy in AIDS patients and a lack of the mineral, selenium.

  • Heart failure. A serious condition in which the heart is not pumping well enough to meet the body’s demand for oxygen. It is sometimes called congestive heart failure because the heart’s failure to pump efficiently often results in congestion in the lungs.

  • Myocarditis. An uncommon inflammation of the heart muscle myocardium. Many people who develop myocarditis recover in a few weeks with little or no side effects and no long-term complications. Unfortunately, there are a small number of people who have severe symptoms and must be hospitalized.

  • Bacterial endocarditis. A potentially fatal infection of the heart or its lining. This condition is rare in HIV-positive patients who have not used intravenous drugs.

    Endocarditis
  • Atherosclerosis. Known as “hardening of the arteries,” this condition occurs when the arteries that supply oxygen-rich blood to the body become partially blocked with brittle plaque deposits. HIV has been shown to be associated with arteriosclerosis in the carotid arteries, which feed the face and brain with oxygen-rich blood. The condition is thought to be related to the medications used to treat HIV.

  • Heart valve disorders. Although several heart valves might be affected in HIV-positive patients, the most dangerous condition is infective endocarditis that occurs in the tricuspid valve. This condition most frequently appears among intravenous (I.V) drug users who are HIV-positive.

It is not fully understood the reason for the prevalence of cardiovascular disorders in people with HIV. Although the virus itself undoubtedly plays a part, researchers have also looked at the role of HIV medications play in the development of heart disease. In recent years, a new therapy known as highly active antiretroviral therapy (HAART) has become available. While this therapy is able to extend the lifespan of HIV-patients, some studies have linked HAART with an increased risk of cardiovascular disease. At least one of the medications included in HAART therapy, protease inhibitors, has been associated with various abnormalities, including:

  • Increased incidence of type 2 diabetes
  • Elevated levels of triglycerides
  • Low levels of HDL (or “good”) cholesterol
  • Abnormal body fat distribution to the abdomen (and indication of metabolic syndrome)

In a study conducted in 2005, researchers reported that HAART increases the risk of stroke and cardiovascular or cerebrovascular events by approximately 16 percent. Antiretroviral treatment has also been linked to a higher risk of heart attack (myocardial infarction) in HIV-infected patients.

Despite this increased risk, most physicians recommend continuing with therapy to treat HIV. However, they may adjust medication levels or recommend that patients reduce as many other risk factors as possible through lifestyle modification (e.g. diet, exercise). In addition, physicians may prescribe medications for treating hypertension and hyperlipidemia in HIV-infected patients at risk for cardiovascular problems.

The link between the heart and HIV is well established but not well understood. It is not yet understood whether the heart is damaged by the HIV virus itself or by opportunistic infections (minor infections that become more dangerous in patients with low immunity) caused by the HIV virus. HIV-positive patients are at greater risk of viral infections (e.g., from the cytomegalovirus or herpes simplex) that can injure the heart regardless of HIV status. It has also been shown that newborns of HIV-positive women have an increased risk of heart function abnormalities, even if the infant is HIV-negative.

Treatment issues related to the heart

HIV patients are treated with a “cocktail” of medications designed to bolster their immune systems while attempting to keep the virus in check. These drugs have become more effective in recent years, enabling patients to live with HIV and AIDS longer than ever before. This has led many researchers to believe that the number of HIV-positive cardiac cases will soon rise. If a heart-related condition is suspected in an HIV patient, the physician may order an echocardiogram, which is a painless test that can show the heart’s thickness, size and function. Routine echocardiogram screening is not recommended in HIV and AIDS patients.

Although the drugs used to treat AIDS patients, including protease inhibitors, are highly effective, a number of them have potential heart-related side effects, including:

  • Intravenous pentamidine could cause a dangerous abnormal heart rhythm (arrhythmia) called Torsade de Pointes.

  • Interferon-alpha has been associated with heart failure or other types of heart disease.

  • Foscarnet could lead to cardiomyopathy.

  • Adriamycin could enlarge the heart and lead to cardiomyopathy.

Zidovudine (AZT), a drug commonly used in HIV therapy, has not been associated with heart problems in humans. Neither has it shown to be harmful to either pregnant women or the developing fetus. HIV-positive women should speak with their physicians prior to becoming pregnant to help ensure that HIV is not transmitted to the baby during pregnancy, or during or just after delivery.

Questions for your doctor

Preparing questions in advance can help patients to have more meaningful discussions with their physicians regarding their conditions. Patients may wish to ask their doctor the following questions related to HIV and the heart:

  1. What heart conditions am I most at risk for developing?

  2. What tests can be used to evaluate my heart health?

  3. What symptoms might indicate a heart problem?

  4. What symptoms indicate the need for immediate attention?

  5. How will my HIV treatments affect my heart?

  6. Will you change my medications if I begin to develop heart problems?

  7. Should I regularly see a cardiologist in addition to my normal doctor?

  8. What can I do to avoid developing heart problems during treatment?

  9. How long will I be at risk for heart problems?

  10. Can you refer me to a dietitian that could help with my diet?
          advertisement
advertisement